๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Prevention of cytomegalovirus infection in the pediatric renal transplant recipient

โœ Scribed by Patricia L. Hibberd; Robert H. Rubin


Publisher
Springer
Year
1991
Tongue
English
Weight
820 KB
Volume
5
Category
Article
ISSN
0931-041X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Stability of human cytomegalovirus genot
โœ Richard Stanton; Diana Westmoreland; Julie D. Fox; Andrew J. Davison; Gavin W.G. ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 348 KB

## Abstract Although most genes are highly conserved among strains of human cytomegalovirus (HCMV), several are unusually variable. By analyzing the sequence of two variable genes (__UL146__ and __UL74__) amplified directly from whole blood DNA extracts, multiple HCMV strains were detected in blood

Characterization of cytomegalovirus isol
โœ Dr. Takumi Kanesaki; Koichi Baba; Kazuko Tanaka; Michio Ishibashi; Hyakuji Yabuu ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 910 KB

The sources of cytomegalovirus (CMV) infection in seropositive renal transplant recipients include reactivation of latent endogenous virus in the recipient, reactivation of latent virus in donated kidney, or both. If infection occurs by either source, viruses isolated from the same recipient should

Acyclovir in preventing cytomegalovirus
โœ C. Legendre; D. Ducloux; A. Ferroni; N. Chkoff; C. Geffrier; C. Rouzioux; H. Kre ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 547 KB

High dose oral acyclovir has been reported to be effective in preventing both cytomegalovirus (CMV) infection and disease in renal transplant recipients. We conducted a case-controlled study in which 42 cadaveric kidney transplant recipients were prophylactically treated with high dose oral acyclovi